24th March 2023
- 0 comments
Antiverse Ltd, a biotechnology company developing a computational antibody drug discovery platform, has closed a $3 million investment round that will enable further development of its AI-driven drug discovery platform.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage